Committed to providing exceptional care and continued support to patients, families and caregivers.
For more information or to refer a patient to the Legacy NCS program, please visit NebraskaCancer.com/Legacy or call Nebraska Cancer Specialists at 402.691.6971.
Phase I trials evaluate the safety of a new drug or a new combination of drugs. These trials involve a small number of patients for whom standard therapies have proven ineffective, and seek to determine a safe dose level and evaluate efficiency.
Our robust Research Department is helping advance cancer research, while offering hope to patients fighting their toughest battles. Through phase I trials, we are able offer first ever access to clinical trial treatments and therapies. Our research department has experience in delivering first-in-human drug trials including studies in which we have treated the first patient ever with new drugs.
In addition to our standard oncology team of physicians, nurse practitioners and case managers, patients in phase I trials will be working closely hand-in-hand with our Research Team.
For more information or to refer a patient to the Legacy NCS program, please visit NebraskaCancer.com/Legacy or call Nebraska Cancer Specialists at 402.334.4773 or by fax at 402.330.7463.
You can also contact our Research Director, Megan Meays at mmeays@nebraskacancer.com.
The Research team at NCS is a robust team of research nurses, assistants, pharmacy techs and data managers.
![]() Dr Ralph Hauke |
![]() Dr Sam Mehr |
![]() Marlene Bridwell |
![]() Megan Meays MAM, CCRC |
![]() Scott Degenhardt, NMAA, MIS |
![]() Gladys Pierce RN,OCN |
![]() Heather Cordes |
![]() Josh Settlemire, RN, BSN, OCN |
![]() Julie Ehlers, MS |